Comerica Bank
FATE icon

Comerica Bank’s Fate Therapeutics FATE Stock Holding History

Comerica Bank’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-82,024
Closed -$64.8K – 3724
2025
Q1 		$64.8K Buy
82,024
+81,877
+55,699% +$100K ﹤0.01% 2722
2024
Q4 		$243 Buy
+147
New +$370 ﹤0.01% 3635
2024
Q2 		– Sell
-879
Closed -$6.45K – 3738
2024
Q1 		$6.45K Buy
879
+350
+66% +$2.17K ﹤0.01% 3278
2023
Q4 		$1.98K Buy
+529
New +$1.25K ﹤0.01% 3525
2022
Q4 		$765K Buy
133,760
+10,320
+8% +$194K 0.01% 1602
2022
Q3 		$2.33M Sell
123,440
-34,890
-22% -$1.01M 0.02% 955
2022
Q2 		$5.15M Buy
158,330
+50,779
+47% +$1.4M 0.04% 519
2022
Q1 		$3.94M Buy
+107,551
New +$4.16M 0.03% 717
2021
Q1 		– Sell
-2,363
Closed -$230K – 2342
2020
Q4 		$230K Buy
+2,363
New +$147K ﹤0.01% 2209

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Comerica Bank's FATE Position: Q2 2025 in Review

Comerica Bank sold out of Fate Therapeutics (FATE) in Q2 2025, closing a stake of 82,024 shares — an estimated $64.8K sold.

Comerica Bank first reported a position in FATE in Q4 2020 and held it in 9 quarters. The position peaked at $5.15M in Q2 2022. 139 funds tracked by Wall St. Rank hold FATE as of Q2 2025.

  • Comerica Bank reported no remaining Fate Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Comerica Bank sold 82,024 Fate Therapeutics shares in Q2 2025, an estimated $64.8K.
  • Comerica Bank first reported a position in Fate Therapeutics in Q4 2020 and held it in 9 quarters.
  • Comerica Bank's Fate Therapeutics position peaked at $5.15M in Q2 2022.
  • 139 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2025.

Based on Comerica Bank's 13F filing for Q2 2025, filed 14 Aug 2025.